Safety of medicines and vaccines – building next generation capability: Trends in Pharmacological Sciences
EU medicine regulator finds possible link between AstraZeneca jab and blood clots | New Europe
Fluid pump implant maker Sequana Medical files for Belgian IPO | Fierce Biotech
EU medicines watchdog greenlights Moderna COVID-19 vaccine | New Europe
Full article: Abstracts presented at the 25th Annual Congress of the Belgian Society of Internal Medicine, 10-11 December 2021, Dolce La Hulpe, La Hulpe, Belgium
How does the Pfizer/BioNTech vaccine work and who will get it? | Coronavirus | The Guardian
ITG - Annual report 2020
Icosavax raises funding to advance RSV/hMPV vaccine programme
NHS Covid drive aims to vaccinate up to 5,000 people daily at each mass centre | Coronavirus | The Guardian
Werkzaamheid van COVID-19 vaccin bij mensen met auto-immuunaandoeningen | Reumanet
FIP Library - FIP - International Pharmaceutical Federation Publications
EU Vaccines Strategy | European Commission
Horizon Europe Vaccines 2.0 - developing the next generation of vaccines
/cloudfront-us-east-2.images.arcpublishing.com/reuters/D7O45EWU3ZOWDHMIVVVU6NULTI.jpg "People with allergic reaction to mRNA vaccines can get 2nd dose; Delta viral load over 1,000 times higher | Reuters")
People with allergic reaction to mRNA vaccines can get 2nd dose; Delta viral load over 1,000 times higher | Reuters
EU reviews J&J COVID-19 vaccine for blood clots, expands AstraZeneca probe | Reuters
Hospira Drug Infusion Pumps Critically Vulnerable | Kaspersky official blog
Canada won't receive any Pfizer shots next week — here's what you need to know about the vaccination campaign | CBC News
A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India - eClinicalMedicine
What's the hold up? Why more vaccines haven't been administered
ITG - Annual report 2020
Vaccines | Free Full-Text | Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice | HTML
Single-Use blogs
Horizon Europe Vaccines 2.0 - developing the next generation of vaccines
